News
-
-
-
-
世基賺檢測財 揪過敏基因 Pharmigene's revenue is increased due to the certified pharmacogenomic testings
Pharmigene's revenue is increased this year due to those certified/licensed pharmacogenomic IVD products, with the boost of recently obtained KFDA approval and previous CFDA approval for HLA-B*1502/HLA-B*5801 kits. -
世基基因檢測套組 獲韓國上市許可 KFDA approval for HLA-B*5801 kit
HLA-B*5801 testing obtained South Korea MFDS approval of class III medical devices. Phargmigene is going to provide kits for major medical centers and clinical laboratories in Korea from November. -
LCM Genect appointed new distributor in Italy
We are very pleased to announce we have appointed LCM Genect to our growing list of worldwide distributors.